Esketamine injection just after childbirth reduces depression in new mothers

Low dose esketamine should be considered for individuals with depressive symptoms in pregnancy, say researchers A single low dose injection of esketamine given immediately after childbirth reduces major depressive episodes in individuals with depressive symptoms during pregnancy (prenatal depression), finds a clinical trial published by The BMJ today. The results ...

2024-06-04T10:23:45+00:0011 April 2024|Press release, The BMJ|

Job insecurity in early adulthood linked to heightened risk of serious alcohol-related illness in later life

Young men seem to be more at risk than young women, long term study suggests Experiencing the sort of job insecurity in early adulthood that is often linked to the gig economy, is linked to a heightened risk of a serious alcohol-related illness in later life, suggest the findings of ...

2024-06-04T10:23:46+00:0010 April 2024|Occupational & Environmental Medicine, Press release|

Evidence for puberty blockers and hormone treatment for gender transition wholly inadequate

Most clinical guidelines currently in use aren’t evidence based either Gender medicine “built on shaky foundations,” says Dr Hilary Cass in The BMJ The evidence on the use of puberty blockers and hormones for children and young people experiencing gender related distress is wholly inadequate, making it impossible to gauge ...

2024-06-04T10:25:37+00:0010 April 2024|Archives of Disease in Childhood, Press release|
Go to Top